References
- TriesscheijnMBaasPSchellensJHStewartFAPhotodynamic therapy in oncologyOncologist2006111034104417030646
- CelliJPSpringBQRizviIImaging and photodynamic therapy: mechanisms, monitoring, and optimizationChem Rev20101102795283820353192
- KruftBIGreerAPhotosensitization reactions in vitro and in vivoPhotochem Photobiol2011871204121321883245
- ChenBPogueBWHoopesPJHasanTVascular and cellular targeting for photodynamic therapyCrit Rev Eukaryot Gene Expr20061627930517206921
- ShirasuNNamSOKurokiMTumor-targeted photodynamic therapyAnticancer Res2013332823283123780966
- KlajnertBRozanekMBryszewskaMDendrimers in photodynamic therapyCurr Med Chem2012194903491222963625
- SchmittFJuillerat-JeanneretLDrug targeting strategies for photodynamic therapyAnticancer Agents Med Chem20121250052522292760
- FDA committee has recommended approval of Photofrin® for palliative treatment of late-stage lung cancerJ Clin Laser Med Surgery199816334
- BaiDXiaXYowCMChuESXuCHypocrellin B-encapsulated nanoparticle-mediated rev-caspase-3 gene transfection and photodynamic therapy on tumor cellsEur J Pharmacol201165049650020970418
- GoffBABlakeJBambergMPHasanTTreatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer modelBr J Cancer199674119411988883404
- BugajAMTargeted photodynamic therapy – a promising strategy of tumor treatmentPhotochem Photobiol Sci2011101097110921547329
- MajorosIJWilliamsCRBakerJRJrCurrent dendrimer applications in cancer diagnosis and therapyCurr Top Med Chem200881165117918855703
- BakerJRJrDendrimer-based nanoparticles for cancer therapyHematology Am Soc Hematol Educ Program200970871920008257
- LiuJGrayWDDavisMELuoYPeptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise reviewInterface Focus2012230732423741608
- ChenHTNeermanMFParrishARSimanekEECytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug deliveryJ Am Chem Soc2004126100441004815303879
- DaftarianPKaiferAELiWPeptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cellsCancer Res2011717452746221987727
- KobayashiHSatoNHiragaA3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic propertiesMagn Reson Med20014545446011241704
- DuanXSheardownHDendrimer crosslinked collagen as a corneal tissue engineering scaffold: mechanical properties and corneal epithelial cell interactionsBiomaterials2006274608461716713624
- ZhangGDHaradaANishiyamaNPolyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancerJ Control Release20039314115014636720
- BattahSHCheeCENakanishiHGerscherSMacRobertAJEdwardsCSynthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapyBioconjug Chem20011298098811716689
- LiWSAidaTDendrimer porphyrins and phthalocyaninesChem Rev20091096047607619769361
- BattahSBalaratnamSCasasAMacromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugatesMol Cancer Ther2007687688517363482
- ChengYSamiaCMeyersJDPanagopoulosIFeiBBurdaCHighly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancerJ Am Chem Soc2008130106431064718642918
- RobyAErdoganSTorchilinVPEnhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicellesCancer Biol Ther200761136114217611407
- WangAZLangerRFarokhzadOCNanoparticle delivery of cancer drugsAnnu Rev Med20126318519821888516
- JardinesLWeissMFowbleBGreeneMneu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancerPathobiology1993612682827905269
- ArteagaCLSliwkowskiMXOsborneCKPerezEAPuglisiFGianniLTreatment of HER2-positive breast cancer: current status and future perspectivesNat Rev Clin Oncol20129163222124364
- HoweLRBrownPHTargeting the HER/EGFR/ErbB family to prevent breast cancerCancer Prev Res (Phila)201141149115721816844
- FeldwischJTolmachevVEngineering of affibody molecules for therapy and diagnosticsMethods Mol Biol201289910312622735949
- LofblomJFeldwischJTolmachevVCarlssonJStahlSFrejdFYAffibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applicationsFEBS Lett20105842670268020388508
- TolmachevVOrlovaANilssonFYFeldwischJWennborgAAbrahmsenLAffibody molecules: potential for in vivo imaging of molecular targets for cancer therapyExpert Opin Biol Ther2007755556817373906
- LoughranSTLoughranNBRyanBJD’SouzaBNWallsDModified His-tag fusion vector for enhanced protein purification by immobilized metal affinity chromatographyAnal Biochem200635514815016814244
- WozniakMTanfaniFBertoliEZoleseGAntosiewiczJA new fluorescence method to detect singlet oxygen inside phospholipid model membranesBiochim et Biophys Acta1991108294100
- GovindarajanSSivakumarJGarimidiPTargeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugateBiomaterials2012332570258222192536
- WuBKerkeniBEgamiTStructured water in polyelectrolyte dendrimers: understanding small angle neutron scattering results through atomistic simulationJ Chem Phys201213614490122502544
- UeharaTIshiiDUemuraTgamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devicesBioconjug Chem20102117518120000792
- ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther20088376176917957183
- GajbhiyeVPalanirajanVKTekadeRKJainNKDendrimers as therapeutic agents: a systematic reviewJ Pharm Pharmacol200961989100319703342
- HuangZA review of progress in clinical photodynamic therapyTechnol Cancer Res Treat2005428329315896084
- PhillipsDToward targeted photodynamic therapyPure Appl Chem201183733748
- KaminskasLMMcLeodVMKellyBDA comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systemsNanomedicine2012810311121704192
- LaiPSLouPJPengCLDoxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapyJ Control Release2007122394617628166
- YinZLiuNMaMWangLHaoYZhangXA novel EGFR-targeted gene delivery system based on complexes self-assembled by EGF, DNA, and activated PAMAM dendrimersInt J Nanomedicine201274625463522942644
- KhdairAHandaHMaoGPanyamJNanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitroEur J Pharm Biopharm20097121422218796331
- FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev20116313615120441782
- FukumuraDJainRKTumor microenvironment abnormalities: causes, consequences, and strategies to normalizeJ Cell Biochem200710193794917171643
- JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol2010765366420838415
- BoohakerRJLeeMWVishnubhotlaPPerezJMKhaledARThe use of therapeutic peptides to target and to kill cancer cellsCurr Med Chem2012193794380422725698
- PearceTRShroffKKokkoliEPeptide targeted lipid nanoparticles for anticancer drug deliveryAdv Mater20122438033822371022674563
- MacEwanSRChilkotiAHarnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agentsWiley Interdiscip Rev Nanomed Nanobiotechnol20135314822977001
- MiyanoTWijagkanalanWKawakamiSYamashitaFHashidaMAnionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cellsMol Pharm201071318132720527783
- MasterAMQiYOleinickNLGuptaASEGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studiesNanomedicine2012865566422024195
- NishiyamaNStapertHRZhangGDLight-harvesting ionic dendrimer porphyrins as new photosensitizers for photodynamic therapyBioconjug Chem200314586612526693
- RemantBKChandrashekaranVChengBRedox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to HER2-positive cancer cellsMol Pharm2014111897190524779647
- GaoJChenKMiaoZAffibody-based nanoprobes for HER2-expressing cell and tumor imagingBiomaterials2011322141214821147502
- NarsireddyAVijayashreeKIrudayarajJManoramaSVRaoNMTargeted in vivo photodynamic therapy with epidermal growth factor receptor-specific peptide linked nanoparticlesInt J Pharm201447142142924939618
- ReddyANAnjaneyuluKBasakPRaoNMManoramaSVA simple approach to the design and functionalization of Fe3O4-Au nanoparticles for biomedical applicationsChempluschem201277284292
- GaleazziSHermansTMPaolinoMMultivalent supramolecular dendrimer-based drugsBiomacromolecules20101118218619957993